Acquisition deepens Elevance Health’s capabilities in specialty pharmacy INDIANAPOLIS–(BUSINESS WIRE)–$ELV–Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such … [Read more…]
New version of ICH reduces notification fatigue with a near perfect false positive rejection rate; and allows medical teams to make faster decisions for improved hemorrhage management SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for the … [Read more…]
BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced its participation in the following upcoming investor conferences: Jefferies London Healthcare Conference on Wednesday, November 16, 2022, at 9:10 a.m. GMT (4:10 a.m. EST) 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022, at 9:15 a.m. EST A live webcast of management’s remarks will be … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences: Jefferies London Healthcare Conference on Wednesday, November 16, 2022 at 2:05 pm GMT (9:05 am ET) at the Waldorf Hilton in London Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 … [Read more…]
Expects to be Profitable in 2024 WIXOM, Mich.–(BUSINESS WIRE)–$RMTI #concentrates–Rockwell Medical, Inc. (“Rockwell” or the “Company”) (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company is reacquiring its distribution rights to its hemodialysis concentrates products from Baxter … [Read more…]
Inclusion of Abcam validated antibodies in CosMx curated protein panel provides the first high-plex spatial multiomic solution at single-cell and subcellular resolution Data from the CosMx human immuno-oncology 64-plex protein panel will be presented at the 37th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC) SEATTLE & CAMBRIDGE, United Kingdom–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, … [Read more…]
With the certification, the company can commercialize the detector in more than 30 new countries WATERLOO, Ontario–(BUSINESS WIRE)–#ECR2020–KA Imaging’s innovative Reveal™ 35C flat panel detector has received EU MDR CE Mark Certificate from the EU Notified Body. The X-ray detector, powered by patented SpectralDR™ technology, is now qualified for sale in any of the 27 … [Read more…]
Poddevin joins DNA Script in a year of immense growth in hiring, financing, commercialization and collaborations. PARIS–(BUSINESS WIRE)–#DNASynthesis–DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, further strengthened its leadership team with the addition of Bruno Poddevin, Ph.D., who brings 30 years of experience in the oligo manufacturing industry to … [Read more…]
HELSINKI–(BUSINESS WIRE)–TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces that the company has opened an office in Boston, to support its increasing US clinical development, partnering and fund-raising activities. The current US clinical trials are run in collaboration with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA and the Merck-Pfizer-Alliance. … [Read more…]
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, today announces the success of its fundraise for approximatively € 9.7 millions, including, on the one hand, a reserved offer intended to a category of … [Read more…]
